Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Kobayashi · SciRah

Researcher profile · Semantic Scholar

H. Kobayashi

Share profile

H. Kobayashi — researcher profile on SciRah

h-index: 28
Works: 192
Citations: 2,983

Most-cited papers

Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab.
Hiroki Ishihara, T. Takagi, T. Kondo, C. Homma +8 more
2019Urologic oncology88 citations
Semantic Scholar
Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma
Hiroki Ishihara, H. Tachibana, T. Takagi, T. Kondo +7 more
2019Targeted oncology68 citations
Semantic Scholar
Acquired cystic disease‐associated renal cell carcinoma is the most common subtype in long‐term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi‐institutional study
T. Kondo, Naoto Sasa, H. Yamada, T. Takagi +7 more
2018Pathology international (Print)46 citations Open access
Semantic Scholar
Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study
Hiroki Ishihara, T. Kondo, K. Omae, T. Takagi +4 more
2017International Journal of Clinical Oncology43 citations Open access
Semantic Scholar
Expansion of human cd T cells for adoptive immunotherapy using a bisphosphonate prodrug
Yoshimasa Tanaka, Kaoru Murata‐Hirai, Masashi Iwasaki, Kenji Matsumoto +9 more
201832 citations
Semantic Scholar
Robot‐assisted laparoscopic versus open partial nephrectomy in patients with chronic kidney disease: A propensity score‐matched comparative analysis of surgical outcomes
T. Takagi, T. Kondo, H. Tachibana, J. Iizuka +4 more
2017International journal of urology31 citations
Semantic Scholar
Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era.
Hiroki Ishihara, T. Takagi, T. Kondo, H. Fukuda +6 more
2020Urologic oncology30 citations
Semantic Scholar
Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution
T. Takagi, Kazuhiko Yoshida, A. Wada, T. Kondo +8 more
2020International Journal of Clinical Oncology28 citations
Semantic Scholar
Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma.
H. Tachibana, T. Kondo, Hiroki Ishihara, H. Fukuda +5 more
2020Japanese Journal of Clinical Oncology28 citations
Semantic Scholar
Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-Assisted Partial Nephrectomy
Ryo Ishiyama, T. Kondo, T. Takagi, J. Iizuka +5 more
2018Journal of endourology27 citations
Semantic Scholar
Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer
T. Kondo, I. Hara, T. Takagi, Y. Kodama +6 more
2017International Journal of Clinical Oncology21 citations
Semantic Scholar
Comparison of Surgical Outcomes Between Resection and Enucleation in Robot-Assisted Laparoscopic Partial Nephrectomy for Renal Tumors According to the Surface-Intermediate-Base Margin Score: A Propensity Score-Matched Study
T. Takagi, T. Kondo, H. Tachibana, J. Iizuka +6 more
2017Journal of endourology21 citations
Semantic Scholar
Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease
T. Takagi, T. Kondo, K. Omae, J. Iizuka +4 more
2016International Urology and Nephrology21 citations
Semantic Scholar
Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era.
T. Takagi, H. Fukuda, Hiroki Ishihara, Kazuhiko Yoshida +7 more
2020Urologic oncology20 citations Open access
Semantic Scholar
Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients
J. Tanaka, N. Tanaka, Yan-Hua Wang, K. Mitsuhashi +12 more
2019Haematologica20 citations Open access
Semantic Scholar
A propensity score-matched comparison of surgical precision obtained by using volumetric analysis between robot-assisted laparoscopic and open partial nephrectomy for T1 renal cell carcinoma: a retrospective non-randomized observational study of initial outcomes
T. Takagi, T. Kondo, H. Tachibana, J. Iizuka +5 more
2016International Urology and Nephrology20 citations
Semantic Scholar
Comparison of Outcomes Between Therapeutic Combinations Based on Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitor Monotherapy for First-Line Therapy of Patients with Advanced Renal Cell Carcinoma Outside of Clinical Trials: A Real-World Retrospective Multi-Institutional Study
Hiroki Ishihara, Yukiaki Nemoto, Kazutaka Nakamura, H. Tachibana +9 more
2023Targeted oncology19 citations
Semantic Scholar
Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
M. Yoshino, Hiroki Ishihara, Yukiaki Nemoto, Kazutaka Nakamura +12 more
2022Japanese Journal of Clinical Oncology19 citations
Semantic Scholar
Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
Yukiaki Nemoto, Hiroki Ishihara, Kazutaka Nakamura, H. Tachibana +9 more
2021International Urology and Nephrology18 citations
Semantic Scholar
Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma
Hiroki Ishihara, T. Takagi, T. Kondo, K. Iwamoto +6 more
2018Japanese Journal of Clinical Oncology18 citations Open access
Semantic Scholar
Peritumoral pseudocapsule status according to pathological characteristics from robot‐assisted laparoscopic partial nephrectomy for localized renal cell carcinoma
T. Takagi, Kazuhiko Yoshida, T. Kondo, H. Kobayashi +5 more
2019International journal of urology17 citations
Semantic Scholar
Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study
T. Takagi, T. Kondo, J. Iizuka, K. Omae +4 more
2016BJU International17 citations Open access
Semantic Scholar
Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy
T. Takagi, H. Fukuda, T. Kondo, Hiroki Ishihara +6 more
2019Targeted oncology16 citations
Semantic Scholar
Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma.
Hiroki Ishihara, T. Kondo, Kazutaka Nakamura, Yukiaki Nemoto +9 more
2021Japanese Journal of Clinical Oncology14 citations
Semantic Scholar
Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney
Kazuhiko Yoshida, T. Kondo, T. Takagi, H. Kobayashi +4 more
2020International Journal of Clinical Oncology14 citations
Semantic Scholar
The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
T. Ikeda, Hiroki Ishihara, T. Takagi, H. Fukuda +7 more
2019Clinical Genitourinary Cancer14 citations
Semantic Scholar
Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma
T. Takagi, Kazuhiko Yoshida, H. Kobayashi, T. Kondo +6 more
2018Japanese Journal of Clinical Oncology14 citations
Semantic Scholar
Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy
Hiroki Ishihara, T. Takagi, T. Kondo, H. Tachibana +5 more
2018International Journal of Clinical Oncology13 citations Open access
Semantic Scholar
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug
Yoshimasa Tanaka, Kaoru Murata‐Hirai, Masashi Iwasaki, Kenji Matsumoto +11 more
2018Cancer Science13 citations Open access
Semantic Scholar
Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
T. Kondo, N. Sassa, H. Yamada, T. Takagi +7 more
2021Pathology (Sydney)12 citations
Semantic Scholar
Possible Application of Ascites-infiltrating Gamma-delta T Cells for Adoptive Immunotherapy
Y. Abe, H. Kobayashi, Yoshika Akizawa, K. Ishitani +2 more
2018Anticancer Research12 citations
Semantic Scholar
Prognostic Impact of Early Treatment Interruption of Nivolumab Plus Ipilimumab Due to Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Multi-Institution Retrospective Study
Hiroki Ishihara, Yukiaki Nemoto, Kazutaka Nakamura, T. Ikeda +11 more
2021Targeted oncology11 citations
Semantic Scholar
Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data.
Hiroki Ishihara, T. Takagi, T. Kondo, H. Fukuda +7 more
2020Japanese Journal of Clinical Oncology11 citations
Semantic Scholar
Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.
Kazuhiko Yoshida, T. Takagi, T. Kondo, H. Kobayashi +6 more
2019Japanese Journal of Clinical Oncology11 citations
Semantic Scholar
Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma
Hiroki Ishihara, T. Kondo, H. Fukuda, Kazuhiko Yoshida +5 more
2017Japanese Journal of Clinical Oncology11 citations Open access
Semantic Scholar
Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma
M. Yoshino, Hiroki Ishihara, Yudai Ishiyama, H. Tachibana +10 more
2021In Vivo10 citations Open access
Semantic Scholar
Comparison of Kidney Function in the Early Postoperative Period in Transperitoneal Robot-Assisted Laparoscopic Partial Nephrectomy Between Anterior and Posterior Renal Tumors: A Propensity Score-Matched Study
T. Takagi, T. Kondo, Kazuhiko Yoshida, H. Kobayashi +4 more
2017Journal of endourology10 citations
Semantic Scholar
Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma
Hiroki Ishihara, Yukiaki Nemoto, Kazutaka Nakamura, H. Tachibana +8 more
2022Targeted oncology9 citations
Semantic Scholar
Changes in Real-World Outcomes in Patients with Metastatic Renal Cell Carcinoma from the Molecular-Targeted Therapy Era to the Immune Checkpoint Inhibitor Era
Hiroki Ishihara, Yukiaki Nemoto, Kazutaka Nakamura, H. Tachibana +9 more
2022Targeted oncology9 citations
Semantic Scholar
Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus.
Shun Watanabe, Hiroki Ishihara, T. Takagi, T. Kondo +7 more
2021Japanese Journal of Clinical Oncology9 citations
Semantic Scholar
Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinoma
Hiroki Ishihara, T. Kondo, Kazuhiko Yoshida, K. Omae +4 more
2017Japanese Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single‐center experience with four cases
K. Omae, T. Kondo, T. Takagi, J. Iizuka +3 more
2016Hemodialysis international. International Symposium on Home Hemodialysis9 citations
Semantic Scholar
Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.
Hiroki Ishihara, Yudai Ishiyama, Yukiaki Nemoto, Kazutaka Nakamura +10 more
2022Clinical Genitourinary Cancer8 citations
Semantic Scholar
Association between tumor contact surface area and parenchymal volume change in robot‐assisted laparoscopic partial nephrectomy carried out using the enucleation technique
T. Takagi, Kazuhiko Yoshida, T. Kondo, H. Kobayashi +4 more
2019International journal of urology8 citations
Semantic Scholar
Impact of sex on prognosis in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
Yukiaki Nemoto, Hiroki Ishihara, Kazutaka Nakamura, H. Tachibana +8 more
2023Japanese Journal of Clinical Oncology7 citations
Semantic Scholar
Negative Effect of Immediate Sunitinib Interruption on Survival in Patients With Metastatic Renal Cell Carcinoma
Ryo Ishiyama, Hiroki Ishihara, T. Kondo, T. Takagi +6 more
2019In Vivo7 citations Open access
Semantic Scholar
Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma.
Hiroki Ishihara, Yukiaki Nemoto, H. Tachibana, H. Fukuda +6 more
2023Japanese Journal of Clinical Oncology6 citations
Semantic Scholar
Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Ryo Ishiyama, K. Omae, T. Kondo, J. Iizuka +6 more
2023Japanese Journal of Clinical Oncology6 citations
Semantic Scholar
Efficacy and Safety of Immunotherapy-Based Combinations as First-Line Therapy for Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria
Yukiaki Nemoto, Hiroki Ishihara, Kazutaka Nakamura, H. Tachibana +9 more
2022Targeted oncology6 citations
Semantic Scholar
Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma
Hiroki Ishihara, H. Tachibana, H. Fukuda, Kazuhiko Yoshida +6 more
2021Urologia internationalis6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Takagi×46
Invite
T. Takagi — researcher profile on SciRah
T. Kondo×46
Invite
T. Kondo — researcher profile on SciRah
J. Iizuka×45
Invite
J. Iizuka — researcher profile on SciRah
Kazuhiko Yoshida×43
Invite
Kazuhiko Yoshida — researcher profile on SciRah

×41

Invite

K. Tanabe — researcher profile on SciRah

Hiroki Ishihara×35

Invite

Hiroki Ishihara — researcher profile on SciRah

Invite

H. Fukuda — researcher profile on SciRah

H. Tachibana×24

Invite

H. Tachibana — researcher profile on SciRah

Invite

H. Ishida — researcher profile on SciRah

Y. Hashimoto×17

Invite

Y. Hashimoto — researcher profile on SciRah

Invite

M. Okumi — researcher profile on SciRah

Invite

K. Omae — researcher profile on SciRah